CYTK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

14.3

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

0.13

EPS Last/This Y

0.23

EPS This/Next Y

1.62

Price

76.72

Target Price

108.4

Analyst Recom

1.22

Performance Q

3.32

Upside

-429.2%

Beta

0.38

Ticker: CYTK

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	CYTK	81.93	0.20	0.04	101773
2026-07-15	CYTK	82.61	0.20	0.00	102858
2026-07-16	CYTK	80.33	0.19	0.05	106294
2026-07-17	CYTK	80.1	0.19	0.08	107351
2026-07-20	CYTK	79.09	0.18	0.07	73458
2026-07-21	CYTK	81.12	0.17	0.33	75817
2026-07-22	CYTK	82.23	0.17	0.06	76155
2026-07-23	CYTK	81.97	0.17	0.31	77793
2026-07-24	CYTK	80.71	0.17	0.11	77731
2026-07-27	CYTK	80.65	0.17	0.10	77779
2026-07-28	CYTK	79.46	0.17	0.11	79128
2026-07-29	CYTK	78.41	0.17	1.01	79267
2026-07-30	CYTK	80.43	0.17	0.07	79377
2026-07-31	CYTK	77.11	0.17	1.42	79452
2026-08-03	CYTK	76.45	0.17	0.74	79579
2026-08-04	CYTK	78.6	0.17	0.13	79707
2026-08-05	CYTK	78.89	0.18	0.22	79281
2026-08-06	CYTK	81.58	0.18	0.12	79291
2026-08-07	CYTK	76.72	0.18	0.59	79636
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	CYTK	81.92	-43.0	-80.3	-6.32
2026-07-15	CYTK	82.59	-43.0	-88.9	-6.32
2026-07-16	CYTK	80.36	-43.0	-61.7	-6.32
2026-07-17	CYTK	80.10	-43.0	-80.1	-6.32
2026-07-20	CYTK	79.10	-43.0	-72.9	-6.32
2026-07-21	CYTK	81.12	-43.0	-102.2	-6.32
2026-07-22	CYTK	82.21	-43.0	-93.1	-6.32
2026-07-23	CYTK	81.97	-43.0	-80.7	-6.32
2026-07-24	CYTK	80.77	-43.0	-71.7	-6.32
2026-07-27	CYTK	80.63	-43.0	-81.7	-6.32
2026-07-28	CYTK	79.47	-43.0	-71.4	-6.32
2026-07-29	CYTK	78.43	-42.9	-72.7	-6.32
2026-07-30	CYTK	80.43	-42.9	-102.5	-6.32
2026-07-31	CYTK	77.09	-42.9	-50.4	-6.31
2026-08-03	CYTK	76.44	-42.9	-75.8	-6.31
2026-08-04	CYTK	76.44	-42.9	-75.8	-6.31
2026-08-05	CYTK	78.88	-42.9	-85.3	-6.31
2026-08-06	CYTK	81.47	-42.9	-107.8	-6.31
2026-08-07	CYTK	76.72	-42.9	-37.6	-6.31
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	CYTK	-7.07	5.04	14.74
2026-07-15	CYTK	-7.07	5.04	14.74
2026-07-16	CYTK	-7.07	5.04	14.74
2026-07-17	CYTK	-7.07	5.04	14.74
2026-07-20	CYTK	-7.07	2.56	14.74
2026-07-21	CYTK	-7.07	2.56	14.74
2026-07-22	CYTK	-7.07	2.56	14.74
2026-07-23	CYTK	-7.07	2.56	14.74
2026-07-24	CYTK	-7.13	2.56	14.74
2026-07-27	CYTK	-7.13	2.57	14.30
2026-07-28	CYTK	-7.25	2.57	14.30
2026-07-29	CYTK	-7.25	2.57	14.30
2026-07-30	CYTK	-7.25	2.57	14.30
2026-07-31	CYTK	-7.48	2.57	14.30
2026-08-03	CYTK	-7.47	3.45	14.30
2026-08-04	CYTK	-7.47	3.45	14.30
2026-08-05	CYTK	-7.47	3.45	14.30
2026-08-06	CYTK	-7.22	3.45	14.30
2026-08-07	CYTK	-7.22	3.45	14.30
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.67

Avg. EPS Est. Current Quarter

-1.6

Avg. EPS Est. Next Quarter

-1.54

Insider Transactions

-7.22

Institutional Transactions

3.45

Beta

0.38

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

30.4

Max Drawdown 5-Year %

-72.4

Target Price

108.4

P/E

Forward P/E

PEG

P/S

141.15

P/B

P/Free Cash Flow

EPS

-7.22

Average EPS Est. Cur. Y

-6.31

EPS Next Y. (Est.)

-4.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1321.12

Relative Volume

1.58

Return on Equity vs Sector %

Return on Equity vs Industry %

89.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

-37.6

◆ CYTK Healthcare

$76.76

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

18/25

Volume

3/15

Valuation

9/20

TP/AR

4/10

Options

8/10

RSI

Range 1M

19.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

12/30

Estimates

3/20

Inst/Vol

9/15

Options

7/10

EPS Yr

6.9%

EPS NY

26.9%

52W%

79.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +41.2% upside

Quality

7/30

Valuation

10/30

Growth

8/25

Stability

9/10

LT Trend

0/5

Upside

+41.2%

Quality

CYTK — P/E HistoricalBiotechnology

Cytokinetics, Incorporated

Sector: Healthcare

Industry: Biotechnology

Employees: 673

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

CYTK

Latest News

—

Caricamento notizie per CYTK…

stock quote shares CYTK – Cytokinetics, Incorporated Stock Price stock today

news today CYTK – Cytokinetics, Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch CYTK – Cytokinetics, Incorporated yahoo finance google finance

stock history CYTK – Cytokinetics, Incorporated invest stock market

stock prices CYTK premarket after hours

ticker CYTK fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CYTK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y